David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$436M |
| 2 |
AbbVie
ABBV
|
+$407M |
| 3 |
Johnson & Johnson
JNJ
|
+$295M |
| 4 |
Gilead Sciences
GILD
|
+$267M |
| 5 |
Starbucks
SBUX
|
+$230M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$407M |
| 2 |
Booking.com
BKNG
|
+$400M |
| 3 |
Citigroup
C
|
+$314M |
| 4 |
SHPG
Shire pic
SHPG
|
+$276M |
| 5 |
PayPal
PYPL
|
+$257M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.04% |
| 2 | Healthcare | 13.44% |
| 3 | Consumer Discretionary | 13.38% |
| 4 | Financials | 7.19% |
| 5 | Industrials | 6.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HTB
2601
HomeTrust Bancshares
HTB
$773M
| $934K | ﹤0.01% |
37,054
+20,310
| +121% | +$542K |
|
2602
Cheesecake Factory
CAKE
$5.74B
| $931K | ﹤0.01% |
19,038
-190,976
| -91% | -$8.78M |
|
|
ROCC
2603
PUT
DELISTED
Ranger Oil Corporation Class A Common Stock
ROCC
| $926K | ﹤0.01% |
21,000
-11,600
| -36% | -$621K |
|
|
VWTR
2604
DELISTED
Vidler Water Resouces, Inc. Common Stock
VWTR
| $926K | ﹤0.01% |
93,557
+14,486
| +18% | +$147K |
|
2605
Factset
FDS
$10.5B
| $919K | ﹤0.01% |
3,700
-14,377
| -80% | -$3.21M |
|
|
VRNT
2606
DELISTED
Verint Systems
VRNT
| $919K | ﹤0.01% |
30,134
-31,771
| -51% | -$808K |
|
|
STEL
2607
DELISTED
Stellar Bancorp
STEL
| $918K | ﹤0.01% |
28,279
-6,172
| -18% | -$199K |
|
|
ARD
2608
DELISTED
Ardagh Group S.A. Class A Common Shares
ARD
| $917K | ﹤0.01% |
70,558
+31,435
| +80% | +$388K |
|
|
BGFV
2609
DELISTED
Big 5 Sporting Goods
BGFV
| $915K | ﹤0.01% |
287,739
+102,365
| +55% | +$370K |
|
2610
CALL
Capri Holdings
CPRI
$1.55B
| $915K | ﹤0.01% |
20,000
-10,000
| -33% | -$437K |
|
2611
Ingles Markets
IMKTA
$1.59B
| $913K | ﹤0.01% |
33,064
+10,965
| +50% | +$322K |
|
|
CBPO
2612
CALL
DELISTED
China Biologic Products Holdings, Inc.
CBPO
| $913K | ﹤0.01% |
+10,000
| New | +$818K |
|
2613
PUT
TripAdvisor
TRIP
$1.16B
| $911K | ﹤0.01% |
17,700
-300
| -2% | -$16.4K |
|
|
QTNT
2614
DELISTED
Quotient Limited Ordinary Shares
QTNT
| $910K | ﹤0.01% |
+2,524
| New | +$888K |
|
|
LNW
2615
PUT
DELISTED
Light & Wonder
LNW
| $907K | ﹤0.01% |
44,400
-47,700
| -52% | -$1.14M |
|
2616
Williams Companies
WMB
$91B
| $903K | ﹤0.01% |
31,444
-3,537
| -10% | -$94.8K |
|
2617
Builders FirstSource
BLDR
$7.39B
| $899K | ﹤0.01% |
67,421
-6,903
| -9% | -$90.7K |
|
2618
Biglari Holdings Class A
BH.A
$1.24B
| $896K | ﹤0.01% |
1,218
-75
| -6% | -$50.2K |
|
|
JBGS
2619
JBG SMITH
JBGS
$723M
| $896K | ﹤0.01% |
21,660
-189,229
| -90% | -$7.43M |
|
2620
Commercial Metals
CMC
$7.57B
| $895K | ﹤0.01% |
52,428
+35,579
| +211% | +$587K |
|
2621
Merchants Bancorp
MBIN
$2.46B
| $892K | ﹤0.01% |
62,232
-16,577
| -21% | -$229K |
|
2622
PUT
Visteon
VC
$2.77B
| $889K | ﹤0.01% |
13,200
-13,800
| -51% | -$1.04M |
|
2623
Arista Networks
ANET
$255B
| $886K | ﹤0.01% |
45,104
+24,480
| +119% | +$388K |
|
|
SVM
2624
Silvercorp Metals
SVM
$2.89B
| $886K | ﹤0.01% |
344,900
+68,300
| +25% | +$165K |
|
2625
PUT
WD-40
WDFC
$2.91B
| $881K | ﹤0.01% |
5,200
-19,100
| -79% | -$3.37M |
|
Similar funds
David Shaw's Q1 2019 Portfolio in Review
As of Q1 2019, David Shaw held 4,169 positions worth $77.4B, up 6.6% from $72.6B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
David Shaw withdrew a net $6.74B in Q1 2019, closing 617 positions and reducing 1,599 holdings. Its most notable exit was Shire pic, an estimated $276M position sold in full.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, David Shaw opened a new position in Lyft worth $159M.
- David Shaw's largest Q1 2019 buy was Lyft: 2,245,851 shares worth $159M.
- David Shaw added most to Pfizer in Q1 2019, an estimated $436M increase.
- David Shaw's biggest Q1 2019 reduction was Bristol-Myers Squibb, cutting an estimated $407M.
- David Shaw fully exited Shire pic in Q1 2019, selling an estimated $276M.
- David Shaw's ten largest holdings make up 9% of its $77.4B portfolio in Q1 2019.
- David Shaw opened 447 new positions and closed 617 in Q1 2019.
- David Shaw's portfolio value rose 6.6% quarter-over-quarter to $77.4B.
Based on D.E. Shaw & Co's 13F filing for Q1 2019, filed 15 May 2019.